Capstone Asset Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-4,760
| Closed | -$228K | – | 1612 |
|
|
2016
Q3 | $228K | Sell |
4,760
-70
| -1% | -$3.35K | 0.01% | 1466 |
|
|
2016
Q2 | $259K | Buy |
4,830
+150
| +3% | +$8.04K | 0.01% | 1375 |
|
|
2016
Q1 | $209K | Buy |
+4,680
| New | +$209K | 0.01% | 1476 |
|
|
2015
Q4 | – | Sell |
-6,980
| Closed | -$222K | – | 1598 |
|
|
2015
Q3 | $222K | Buy |
6,980
+210
| +3% | +$6.68K | 0.01% | 1429 |
|
|
2015
Q2 | $224K | Sell |
6,770
-3,720
| -35% | -$123K | 0.01% | 1463 |
|
|
2015
Q1 | $432K | Buy |
10,490
+240
| +2% | +$9.88K | 0.01% | 1172 |
|
|
2014
Q4 | $418K | Sell |
10,250
-920
| -8% | -$37.5K | 0.01% | 1155 |
|
|
2014
Q3 | $409K | Buy |
11,170
+590
| +6% | +$21.6K | 0.01% | 1143 |
|
|
2014
Q2 | $490K | Buy |
10,580
+1,139
| +12% | +$52.8K | 0.02% | 1082 |
|
|
2014
Q1 | $388K | Buy |
9,441
+130
| +1% | +$5.34K | 0.01% | 1250 |
|
|
2013
Q4 | $355K | Buy |
+9,311
| New | +$355K | 0.01% | 1392 |
|